Edward D. Bashaw

1.3k total citations · 1 hit paper
21 papers, 587 citations indexed

About

Edward D. Bashaw is a scholar working on Dermatology, Pediatrics, Perinatology and Child Health and Pharmaceutical Science. According to data from OpenAlex, Edward D. Bashaw has authored 21 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pharmaceutical Science. Recurrent topics in Edward D. Bashaw's work include Advancements in Transdermal Drug Delivery (6 papers), Pharmaceutical studies and practices (5 papers) and Dermatology and Skin Diseases (4 papers). Edward D. Bashaw is often cited by papers focused on Advancements in Transdermal Drug Delivery (6 papers), Pharmaceutical studies and practices (5 papers) and Dermatology and Skin Diseases (4 papers). Edward D. Bashaw collaborates with scholars based in United States, Denmark and Germany. Edward D. Bashaw's co-authors include Luke S. Oh, Charles J. Ganley, Robbert Zusterzeel, Issam Zineh, David G. Strauss, Sergio G. Coelho, Murali K. Matta, Nageswara Rao Pilli, Vikram Patel and Carlos Sanabria and has published in prestigious journals such as JAMA, Nature Reviews Drug Discovery and Journal of Controlled Release.

In The Last Decade

Edward D. Bashaw

21 papers receiving 569 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients

2019 215 citations Murali K. Matta, Robbert Zusterzeel et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward D. Bashaw United States	10	322	122	91	58	50	21	587
Robbert Zusterzeel United States	13	281 0.9×	131 1.1×	36 0.4×	73 1.3×	98 2.0×	29	982
S. Kemp United States	4	277 0.9×	121 1.0×	35 0.4×	52 0.9×	46 0.9×	7	485
Joël Claveau Canada	17	426 1.3×	73 0.6×	28 0.3×	87 1.5×	141 2.8×	37	874
E.V. Buehler United States	13	369 1.1×	122 1.0×	40 0.4×	15 0.3×	58 1.2×	26	750
Camille Géniès France	14	150 0.5×	128 1.0×	121 1.3×	13 0.2×	56 1.1×	26	436
A Boman Sweden	11	282 0.9×	88 0.7×	37 0.4×	14 0.2×	57 1.1×	28	541
Andreas Schepky Germany	18	503 1.6×	206 1.7×	214 2.4×	7 0.1×	77 1.5×	43	941
Costanza Rovida Italy	16	318 1.0×	368 3.0×	23 0.3×	19 0.3×	191 3.8×	32	1.2k
H Ippen Germany	15	366 1.1×	87 0.7×	27 0.3×	184 3.2×	423 8.5×	130	1.0k

Countries citing papers authored by Edward D. Bashaw

Since Specialization

Citations

This map shows the geographic impact of Edward D. Bashaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Bashaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Bashaw more than expected).

Fields of papers citing papers by Edward D. Bashaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Bashaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Bashaw. The network helps show where Edward D. Bashaw may publish in the future.

Co-authorship network of co-authors of Edward D. Bashaw

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Bashaw. A scholar is included among the top collaborators of Edward D. Bashaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Bashaw. Edward D. Bashaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abulwerdi, Gelareh, et al.. (2023). Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020. Clinical and Translational Science. 16(10). 2046–2057. 1 indexed citations

Oh, Luke S., et al.. (2020). In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products. Therapeutic Innovation & Regulatory Science. 54(3). 693–700. 14 indexed citations

Matta, Murali K., Jeffry Florian, Robbert Zusterzeel, et al.. (2020). Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients. JAMA. 323(3). 256–256. 183 indexed citations

Oh, Luke S., et al.. (2019). In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products. Therapeutic Innovation & Regulatory Science. 3593147085–3593147085. 7 indexed citations

Matta, Murali K., Robbert Zusterzeel, Nageswara Rao Pilli, et al.. (2019). Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients. JAMA. 321(21). 2082–2082. 215 indexed citations breakdown →

Li, Fang, Myong‐Jin Kim, Theresa Kehoe, et al.. (2018). Regulatory Perspectives in Pharmacometric Models of Osteoporosis. The Journal of Clinical Pharmacology. 58(5). 572–585. 11 indexed citations

Dubcenco, Elena, et al.. (2017). A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety. Clinical and Translational Science. 10(5). 387–394. 5 indexed citations

Raney, Sam G., et al.. (2016). Navigating sticky areas in transdermal product development. Journal of Controlled Release. 233. 1–9. 23 indexed citations

SHON, J, et al.. (2016). Teratogenic drugs and their drug interactions with hormonal contraceptives. Clinical Pharmacology & Therapeutics. 100(3). 217–219. 5 indexed citations

10.

Bashaw, Edward D.. (2016). A clinical pharmacology‐regulatory perspective on the approval of drugs for rare diseases. Clinical Pharmacology & Therapeutics. 100(4). 327–329. 4 indexed citations

11.

Bashaw, Edward D., et al.. (2014). Maximal Usage Trial: An Overview of the Design of Systemic Bioavailability Trial for Topical Dermatological Products. Therapeutic Innovation & Regulatory Science. 49(1). 108–115. 22 indexed citations

12.

Bashaw, Edward D., et al.. (2014). Bioanalytical Method Validation: Concepts, Expectations and Challenges in Small Molecule and Macromolecule—A Report of PITTCON 2013 Symposium. The AAPS Journal. 16(3). 586–591. 4 indexed citations

13.

Wu, Fang, Lu Gaohua, Ping Zhao, et al.. (2014). Predicting Nonlinear Pharmacokinetics of Omeprazole Enantiomers and Racemic Drug Using Physiologically Based Pharmacokinetic Modeling and Simulation: Application to Predict Drug/Genetic Interactions. Pharmaceutical Research. 31(8). 1919–1929. 24 indexed citations

14.

Yu, Chongwoo & Edward D. Bashaw. (2014). Regulatory Perspective of Bioanalysis from A Clinical Pharmacology Reviewer Standpoint: Do You See What I See?. Bioanalysis. 6(4). 505–510. 6 indexed citations

15.

Bashaw, Edward D., et al.. (2014). Applications of dermal microdialysis: a review. Journal of Drug Delivery Science and Technology. 24(3). 259–269. 11 indexed citations

16.

Bashaw, Edward D. & Lanyan Fang. (2012). Clinical Pharmacology and Orphan Drugs: An Informational Inventory 2006–2010. Clinical Pharmacology & Therapeutics. 91(5). 932–936. 10 indexed citations

17.

Bashaw, Edward D., et al.. (2011). Clinical Pharmacology for Development of Topical Dermatological Products: Present and Future Opportunities for Safety and Efficacy. Clinical Pharmacology & Therapeutics. 89(2). 167–169. 4 indexed citations

18.

Bashaw, Edward D., Shiew‐Mei Huang, Timothy R. Coté, et al.. (2011). Clinical pharmacology as a cornerstone of orphan drug development. Nature Reviews Drug Discovery. 10(11). 795–796. 19 indexed citations

19.

Bashaw, Edward D., et al.. (1995). Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade.. PubMed. 33(9). 524–9. 7 indexed citations

20.

Bashaw, Edward D., et al.. (1988). Visual Compatibility of Zidovudine with Other Injectable Drugs During Simulated Y-Site Administration. American Journal of Health-System Pharmacy. 45(12). 2532–2533. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact